Header5

The simple corporate scheme behind massive US Brand Drug Prices

My 7-year whistleblower effort
"People Before Profits"

A National Crisis: Extreme U.S. Pricing Abuse

A Decade-Plus of Avoidable Massive U.S. Brand Drug Price Increases

Two Whistleblower Cases: Unprecedented Public and Taxpayer Financial Harm

The Most Extreme Abuse: "Old" U.S. Blockbuster Brand Drugs Facing Severe Competition

  • Massive U.S. pharma sales/profits over the past decade-plus
    • Driven by 5-10 fold price increases, while use by doctors and patients plummeting -40-70%
    • THIS CANNOT HAPPEN IN A LEGITIMATE U.S. PHARMACEUTICAL MARKET
    • THIS SECRET PHARMA/HEALTH INSURER/PBM "FEE" SCHEME  IS THE ONLY EXPLANATION
  • Huge "fees" secretly paid by pharma to the dominant health insurer/PBMs "partners", directly tied to massive "sticker" prices and price increases
    • Severe U.S. drug costs passed on to U.S. patients, families, businesses and taxpayers

A Systemic Scheme and An Escalating National Crisis

  • The collusive pricing scheme that began in Medicare Part D has expanded across the entire U.S. health insurance market
  • After a decade of abuse, "old" U.S. brand drugs now routinely cost 8-10 fold higher than in Europe
  • Massive price increases for "old" brands has led to even higher prices for new U.S. brand drugs
  • Many other U.S. brand drugs involved beyond the Whistleblower cases
    • Epipen, Acthar Gel, Valeant Pharmaceuticals, and many others
    • Purdue's Oxycontin and the opioid crisis

Severe Patient and Family Harm

  • Diabetics dying without insulin
  • Severely ill patients losing access to life-saving drugs
  • Rising financial distress – bankruptcies
  • Rising health insurance premiums, increased healthcare costs and deteriorating coverage for all Americans

Receive the Latest News

Your email is 100% safe.
Your privacy will be respected.
!
!
Something went wrong. Please check your entries and try again.
Scroll to Top